CKLSF (CK Life Sciences International Holdings) Ending Cash Position: $77.5 Mil (As of Dec. 2025)


CKLSF CK Life Sciences International Holdings Inc CKLSF
39 GF Score
Price $0.09
GF Value $0.11
! 5 Warning Signs
View Full Analysis

What is CK Life Sciences International Holdings Ending Cash Position?

CK Life Sciences International Holdings CKLSF +28.57% 39 Ending Cash Position is $77.5 Mil as of Dec. 2025. GuruFocus rates CKLSF with a GF Score™ of 39/100 and a GF Value™ of $0.11. The stock has 5 warning signs investors should review.

CK Life Sciences International Holdings's Ending Cash Position for the quarter that ended in Dec. 2025 was $77.5 Mil.

CK Life Sciences International Holdings's quarterly Ending Cash Position increased from Dec. 2024 ($71.3 Mil) to Jun. 2025 ($100.8 Mil) but then declined from Jun. 2025 ($100.8 Mil) to Dec. 2025 ($77.5 Mil).

CK Life Sciences International Holdings's annual Ending Cash Position declined from Dec. 2023 ($85.1 Mil) to Dec. 2024 ($71.3 Mil) but then increased from Dec. 2024 ($71.3 Mil) to Dec. 2025 ($77.5 Mil).

CK Life Sciences International Holdings Ending Cash Position Related Terms

CK Life Sciences International Holdings Ending Cash Position Historical Data

* Premium members only.

The historical data trend for CK Life Sciences International Holdings's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CK Life Sciences International Holdings Ending Cash Position Chart

CK Life Sciences International Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 114.22 88.88 85.06 71.27 77.51

CK Life Sciences International Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 85.06 70.32 71.27 100.80 77.51
CKLSF
39GF Score
CK Life Sciences International Holdings Inc CKLSF
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CK Life Sciences International Holdings Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

CK Life Sciences International Holdings's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=71.197+6.31
=77.5

CK Life Sciences International Holdings's Ending Cash Position for the quarter that ended in Dec. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=101.674+-24.167
=77.5

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $77.5 Mil mean?
CK Life Sciences International Holdings (CKLSF) has a Ending Cash Position of $77.5 Mil as of Dec. 2025. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on CK Life Sciences International Holdings and its competitors.
Is CK Life Sciences International Holdings' Ending Cash Position too high?
CK Life Sciences International Holdings' current Ending Cash Position is $77.5 Mil. Overall, CK Life Sciences International Holdings has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does CK Life Sciences International Holdings' Ending Cash Position compare to VRTX and REGN?
CK Life Sciences International Holdings' Ending Cash Position of $77.5 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on CK Life Sciences International Holdings and its competitors. CK Life Sciences International Holdings's current Ending Cash Position is $77.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CK Life Sciences International Holdings stock overvalued right now?
CK Life Sciences International Holdings (CKLSF) has a current Ending Cash Position of $77.5 Mil. The stock's GF Value™ is $0.11, compared to a current price of $0.09 — trading 18.2% below its estimated fair value. The current Ending Cash Position is $77.5 Mil. CK Life Sciences International Holdings' overall GF Score™ is 39/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For CK Life Sciences International Holdings (CKLSF), the current Ending Cash Position is $77.5 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CK Life Sciences International Holdings (CKLSF) Overvalued in 2026?

Based on GuruFocus' analysis, CK Life Sciences International Holdings stock appears to be undervalued. The current stock price of $0.09 is trading 18.2% below its estimated GF Value™ of $0.11.

Key valuation signals for CKLSF:

  • Ending Cash Position: $77.5 Mil
  • GF Value™: $0.11 vs. price of $0.09 (18.2% below fair value)
  • GF Score™: 39/100 with 5 warning signs

No single metric tells the full story. See the CKLSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CK Life Sciences International Holdings Business Description

Other Exchanges 00775:Hong Kong
Address 2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG
CK Life Sciences International Holdings Inc is an international life sciences company. It is engaged in research and development, manufacturing, commercialization, marketing and selling of health and agriculture-related products, as well as investment in a portfolio of vineyards, and various financial and investment products. Its pipeline includes Seviprotimut-L, TTX-MC138, Seviprotimut-L + TTX-MC138, TTX-RIGA, Halneuron, among others. Its segments include Agriculture-related, Nutraceutical, and Pharmaceuticals & Diagnostics R&D with the majority of the revenue deriving from Nutraceutical segment. Geographically it operates in Asia Pacific that derives the majority of the revenue and North America.
39GF Score

Get the complete analysis for CKLSF

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.09
Price
$0.11
GF Value